Publications by authors named "Cesar Andres Velasquez Escandon"
Impact of New Onset Atrial Fibrillation in Hospitalized Patients with COVID-19. Results of the "ACO-VID" Registry.
Juan José Cerezo Manchado Teodoro Iturbe Hernández María Del Carmen Martínez Pacheco Ignacio Gil Ortega Desirée Campoy Cesar Andres Velasquez Escandon
Clin Appl Thromb Hemost
January 2024
Article Synopsis
- The study examined the effects of new-onset atrial fibrillation (AF) on patients hospitalized for COVID-19, particularly looking at those over 55 years old.
- A total of 668 patients were analyzed, revealing that those with new-onset AF had more comorbid conditions and faced higher rates of complications like major bleeding and cardiovascular mortality compared to patients without AF.
- The findings suggest that while new-onset AF in COVID-19 patients may lead to worse health outcomes, the severity of these outcomes was also influenced by the dosage of anticoagulants administered.
Impact of atrial fibrillation and anticoagulation on the risk of death, thromboembolic disease and bleeding in patients with COVID-19: the ACO-VID Registry.
Juan José Cerezo Manchado Teodoro Iturbe Hernández María Del Carmen Martínez Pacheco Ignacio Gil Ortega Desirée Campoy
Curr Med Res Opin
June 2023
Objective: To describe the clinical profile, risk of complications and impact of anticoagulation in COVID-19 hospitalized patients, according to the presence of atrial fibrillation (AF).
Methods: Multicenter, retrospective, and observational study that consecutively included patients >55 years admitted with COVID-19 from March to October 2020. In AF patients, anticoagulation was chosen based on clinicians' judgment.